Table 2.

Vorinostat in CTCL: Patient demographics^a

Demographic	No. of patients	%
No. of patients	33
Sex
Male	18	55
Female	15	45
Median age, years	67
Performance status
Stage IA	1	3
Stage IB	2	6
Stage IIA	1	3
Stage ≥IIB	29	88
Prior therapy
Chemotherapy	29	88
Ontak	14	42
Bexarotene	22	67
Failed ECP+	15	45

^aPhase 2A

Abbreviation: ECP, extracorporeal photopheresis.